1. Home
  2. Live Updates
  3. Genentech actemra

Live Breaking News & Updates on Genentech actemra

Stay informed with the latest breaking news from Genentech actemra on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Genentech actemra and stay connected to the pulse of your community

Biologics and Biosimilars Landscape: IP, Policy, and Market Developments | Fish & Richardson

In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price...

West-virginia , United-states , California , Johns-hopkins-university , Maryland , Robertm-califf , Eli-lilly-emgality , Genentech-actemra , Janssen-stelara , Samsung-bioepis-merck , Eli-lilly-rezvoglar , Chugai-seiyaku-kabushiki-kaisha

Charting New Paths: Non-TNF's Evolving in Rheumatoid

Although crowded, the RA market contains clear pathways for existing players and new entrants to navigate the evolving landscape and expand their market...

Sanofi-regeneron-kevzara , Abbvie-humira , Eli-lilly-olumiant , Genentech-actemra , Amgen-enbrel , Abbvie-rinvoq , Spherix-network , Linkedin , Spherix-global-insight , Patient-chart-dynamix , Rheumatoid-arthritis , Eli-lilly

Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market

Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

Genentech-actemra , Sanofi-regeneron-kevzara , Amgen-enbrel , Abbvie-rinvoq , Abbvie-humira , Maxine-yarnall , Eli-lilly-olumiant , Spherix-network , Linkedin , Spherix-global-insight , Patient-chart-dynamix , Rheumatoid-arthritis

Pearce IP BioBlast w/e 02 Feb 2024

Regeneron announced that its marketing authorisation application (MAA) for linvoseltamab to treat adult patients with relapsed/refractory (R/R)…

Philippines , Germany , Denmark , Danish , Genentech-lucentis , Polpharma-biologics , Daiichi-sankyo , Daiichi-sankyo-biologics , Fresenius-kabi , Xbrane-biopharma , Genentech-actemra , Daiichi-sankyo-enhertu

BioBlast w/e 15 Dec 23

Korea Biomed reported that LG Chem’s Xelenka®, biosimilar to AbbVie’s Humira® (adalimumab), has been approved by the Korean Ministry of Food and Drug…

Taiwan , Slovenia , South-korea , Japan , Lendava , Lendava-lendva , Korea , Samsung-biologics , Biomed-nona-biosciences , Nona-biosciences , Genentech-avastin , Seagen-astella-padcev

FDA Approves Biogen Biosimilar for Genentech's Actemra® | McDonnell Boehnen Hulbert & Berghoff LLP

On September 29, the U.S. Food and Drug Administration announced approval of Biogen's Tofidence® (tocilizumab-bavi) as a biosimilar to Genentech's Actemra®, a drug approved for treating...

Genentech-actemra , Drug-administration , Mcdonnell-boehnen-hulbert-berghoff , Mcdonnell-boehnen-hulbert ,

Biogen's Actemra biosimilar approved by FDA to treat adult and paediatric arthritis

Biogen's Actemra biosimilar approved by FDA to treat adult and paediatric arthritis
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

China , Hong-kong , Taiwan , Macau , Genentech-actemra , Ian-henshaw , Drug-administration ,

BioBlast f/e 16 Jun 23

BioBlast f/e 16 Jun 23
lexology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lexology.com Daily Mail and Mail on Sunday newspapers.

India , West-virginia , United-states , Colombia , United-kingdom , Canada , South-korea , Brazil , China , Mexico , New-zealand , Ecuador

Roche Diagnostics Revenues Essentially Flat in 2022

Molecular lab revenues fell 17 percent during the year, while core lab sales were up 3 percent and point-of-care revenues grew 15 percent. 

Boston , Massachusetts , United-states , Dana-farber-cancer-institute , America , Teresa-graham , Levi-garraway , Alan-hippe , Genentech-actemra , Matt-sause , Molecular-lab , Broad-institute

Implications of Expanded Biosimilar Use in the United States' Dermatology, Gastroenterology, and Rheumatology Markets Highlighted in New Spherix Study

/PRNewswire/ -- Biosimilars are biopharmaceutical products that are nearly identical copies of drugs that have previously been licensed (reference products),...

United-states , Amgen-enbrel , Samsung-biopi-hadlima , Boehringer-ingelheim-cyltezo , Janssen-stelara , Takeda-entyvio , Abbvie-humira , Prnewswire-biosimilars , Merck-hadlima , Paul-zimmerman , Amgen-avsola , Amgen-amjevita